In contrast to heparin, enoxaparin:: (A) Can be used without monitoring the patient's aPTT, (B) Is less likely to have a teratogenic effect, (C) Is more likely to be given intravenously, (D) Is more likely to cause thrombosis and thrombocytopenia
Answer is A. Enoxaprin is a LMW heparin. It does not require monitoring. Both heparin as well as enoxaprin do not cross placenta and are not teratogenic.